Original language | English (US) |
---|---|
Pages (from-to) | 659-702 |
Number of pages | 44 |
Journal | Hepatology |
Volume | 77 |
Issue number | 2 |
DOIs | |
State | Published - Feb 2023 |
ASJC Scopus subject areas
- Hepatology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Hepatology, Vol. 77, No. 2, 02.2023, p. 659-702.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma
AU - Bowlus, Christopher L.
AU - Arrivé, Lionel
AU - Bergquist, Annika
AU - Deneau, Mark
AU - Forman, Lisa
AU - Ilyas, Sumera I.
AU - Lunsford, Keri E.
AU - Martinez, Mercedes
AU - Sapisochin, Gonzalo
AU - Shroff, Rachna
AU - Tabibian, James H.
AU - Assis, David N.
N1 - Funding Information: Dr. Bergquist advises Ipsen and received grants from Gilead. Dr. Bowlus received grants from Gilead, Bristol‐Myers Squibb, GlaxoSmithKline, Mirum, Genkyotex, Boston Scientific, Intercept, Target, Novartis, BiomX, CymaBay, Genfit, COUR and Pliant. Dr. Assis received grants from Gilead. Dr. Sapisochin consults and advises Integra. He consults and received grants from Roche. He consults for AstraZeneca, Novartis and Evidera. Dr. Forman received grants from Gilead, CymaBay and Mirum. Dr. Deneau consults for Gilead, HighTide and Mirum. Dr. Shroff advises and is on the speakers’ bureau for Servier. She advises and received grants from Merck and QED. She consults for SYROS. She advises AstraZeneca, Boehringer Ingelheim, Genentech, CAMI, Clovis, Incyte and Zymeworks. She received grants from Bayer, Bristol‐Myers Squibb, Exelixis, IMV, LOXO, Novocure, NUCANA, Pieris, Rafeal, Seagen and Taiho. Dr. Ilyas consults for AstraZeneca. Dr. Tabibian consults for Olympus. Funding Information: Funding for the development of this Practice Guidance was provided by the American Association for the Study of Liver Diseases.
PY - 2023/2
Y1 - 2023/2
UR - http://www.scopus.com/inward/record.url?scp=85140232889&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85140232889&partnerID=8YFLogxK
U2 - 10.1002/hep.32771
DO - 10.1002/hep.32771
M3 - Article
C2 - 36083140
AN - SCOPUS:85140232889
SN - 0270-9139
VL - 77
SP - 659
EP - 702
JO - Hepatology
JF - Hepatology
IS - 2
ER -